SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-24-001480
Filing Date
2024-02-13
Accepted
2024-02-13 16:33:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 BIODEXA PHARMACEUTICALS PLC p24-0819sc13ga.htm SC 13G/A 111775
  Complete submission text file 0000902664-24-001480.txt   113462
Mailing Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ
Business Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ 44 (0)1235 888300
Biodexa Pharmaceuticals Plc (Subject) CIK: 0001643918 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89366 | Film No.: 24626642
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 82 EAST ALLENDALE ROAD, SUITE 5B SADDLE RIVER NJ 07458
Business Address 82 EAST ALLENDALE ROAD, SUITE 5B SADDLE RIVER NJ 07458 201-391-1839
Cavalry Fund I LP (Filed by) CIK: 0001677197 (see all company filings)

IRS No.: 464484680 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A